Stock Updates

How has Sanofi:(NYSE:SNY) performed recently?

Sanofi (NYSE: SNY) is a large market cap stock with a market cap of 103676.25. It is in the Drug Manufacturers – Major industry and sector Healthcare, with a current P/E of 22.7, a forward P/E of 13.19 and EPS of 1.77. At a stock price of 40.19 (0.07%) it has a dividend yield of 4.13%.

EPS growth for the last five years have been -4.40%, more recently this last year it has grown by 4.10%. The next year growth is going to be about -1.62% and more long-term 6.40% after five years. EPS growth quarter over quarter is -56.00%. Sales growth for the past five years have been 0.50% and sales growth quarter over quarter is -54.00%.

For performance, Sanofi the past week has seen a gain of -0.40%. For the last month performance for Sanofi is -4.31%. While the last quarter is 2.55% and half year, 7.36%. Finally for the year, performance is -21.42%.

The 52-week high for Sanofi, is at -21.63%, and for the 52-week low it comes to a value of 11.30%. The 20-day simple moving average is -1.60% and -0.80% for the 200-day simple moving average.

Volatility for the week is at 0.83%, and for the month it is 1.07%. Sanofi, has a target price of 51.33.

In terms of debt, long term debt/equity is 0.27, and for total debt/equity Sanofi has 0.32. The gross margin is 68.90%, while operating margin is *TBA, the profit margin is *TBA. The current ratio is 1.5 and the quick ratio is 1.

Insider ownership is at 16.40%, with instituitional ownership at 10.10%. Sanofi has a payout ratio of *TBA. With the total shares outstanding coming to 2581.58. The shares float is 2304.07, with the float short at 0.15%, with short ratio coming to 1.49.

In terms of returns, the return on assets see Sanofi, get *TBA, with its returns on investment at 6.50%. Return on equity is *TBA. So will the investors see the target price of 51.33, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Tony Dabbs

Leave a Comment